BAMF Health is ready to roll

Jan says he had run out of treatment options for his metastatic prostate cancer, but what he heard when he came to BAMF was hope.

Newly published research details BAMF Health’s collaboration with the National Cancer Institute, Leidos Biomedical Research Inc., and Yale University on the Artificial Intelligence and Medical Imaging (AIMI) project.

BAMF Health will be a site for Radiopharma Theranostics’ clinical trial and will also be manufacturing 18F-RAD 101 for other trial sites.